Known targets — ChEMBL curated mechanism
ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2
The experimentally established mechanism targets of Tipepidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SRPK1 | Q96SB4 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 3/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tipepidine SCHEMBL410090 | 0.83 | NOS3 (0.43) | KDM4ETSHRALDH1A1LMNAALOX15 | |
| Tipepidine SCHEMBL30827547 | 0.82 | NOS3 (0.42) | TSHRALDH1A1LMNAALOX15MEN1 | |
| Tipepidine SCHEMBL11026418 | 0.82 | HPGDS (0.43) | KDM4ETSHRALDH1A1LMNAMAPT | |
| Tipepidine SCHEMBL13723968 | 0.73 | OPRM1 (0.35) | KDM4ETSHRALDH1A1MAPTMEN1 | |
| Tipepidine SCHEMBL28142103 | 0.69 | OPRM1 (0.34) | TSHRALDH1A1LMNAMEN1KMT2A | |
| Citric Acid SCHEMBL7204691 | 0.67 | ALDH1A1 (0.58) | KDM4ETSHRALDH1A1LMNAMAPT | |
| Citric Acid SCHEMBL7204241 | 0.67 | ALDH1A1 (0.58) | KDM4ETSHRALDH1A1LMNAMAPT | |
| Citric Acid SCHEMBL27985707 | 0.64 | ALDH1A1 (0.42) | KDM4ETSHRALDH1A1LMNAMAPT | |
| Citric Acid SCHEMBL2724333 | 0.64 | BRD4 (0.55) | KDM4ETSHRALDH1A1LMNAMAPT | |
| Citric Acid SCHEMBL28991395 | 0.63 | BRD4 (0.53) | KDM4ETSHRALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 105 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025009819-A1 | CUTTABLE AND CONSUMABLE TAPE-TYPE OR BAR-TYPE PREPARATION ENABLING DRUG DOSE CONTROL THROUGH LENGTH | 충북대학교 산학협력단 | 2025-01-09 | — | — | WO | claimed |
| EP-1558214-B1 | MICROEMULSION CONCENTRATE FOR ORAL ADMINISTRATION OF WATER-INSOLUBLE ANTI-COLD DRUG AND METHOD FOR PREPARING SAME | HANMI PHARM IND CO LTD (KR) | 2012-09-12 | — | — | EP | claimed |
| US-20090169682-A1 | Functional Masticatory Material, Method Of Producing The Same And Method Of Using The Same | MEIJI PHARMACEUTICAL CO., LTD. (JP) | 2009-07-02 | — | — | US | claimed |
| US-20060062810-A1 | Microemulsion concentrate for oral administration of water-insoluble anti-cold drug and method for preparing same | HANMI PHARM CO., LTD. (KR) | 2006-03-23 | — | — | US | claimed |
| WO-2005094832-A1 | COMPOSITIONS COMPRISING MELOXICAM | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2005-10-13 | — | — | WO | claimed |
| EP-1558214-A1 | MICROEMULSION CONCENTRATE FOR ORAL ADMINISTRATION OF WATER-INSOLUBLE ANTI-COLD DRUG AND METHOD FOR PREPARING SAME | Hanmi Pharm. Co., Ltd. (KR) | 2005-08-03 | — | — | EP | claimed |
| WO-2004041249-A1 | MICROEMULSION CONCENTRATE FOR ORAL ADMINISTRATION OF WATER-INSOLUBLE ANTI-COLD DRUG AND METHOD FOR PREPARING SAME | HANMI PHARM. CO., LTD. (KR) | 2004-05-21 | — | — | WO | claimed |
| JP-62072688-A | — | — | None | — | — | JP | disclosed |
| JP-5139996-A | — | — | None | — | — | JP | disclosed |
| EP-4692178-A1 | CELLULOSE POWDER AND MOLDED BODY | Asahi Kasei Kabushiki Kaisha (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-12427113-B2 | Cellulose composition, tablet, and orally disintegrating tablet | ASAHI KASEI KABUSHIKI KAISHA (JP) | 2025-09-30 | — | — | US | disclosed |
| WO-2025121315-A1 | CELLULOSE POWDER AND MOLDED BODY | 旭化成株式会社 | 2025-06-12 | — | — | WO | disclosed |
| WO-2025105451-A1 | SOLID PREPARATION | 第一三共ヘルスケア株式会社 | 2025-05-22 | — | — | WO | disclosed |
| EP-0631782-B1 | Stabilized solid pharmaceutical preparation containing dextromethorphan, phenylpropanolamine and caffeine | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1999-05-06 | — | — | EP | disclosed |
| US-5726180-A | CAFFEINE, DEXTROMETHORPHAN, PHENYLPROPANOLAMINE, IBUPROFEN | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1998-03-10 | — | — | US | disclosed |
| US-5629316-A | Stabilized solid pharmaceutical preparation and method of producing the same | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-05-13 | — | — | US | disclosed |
| EP-0631782-A1 | Stabilized solid pharmaceutical preparation containing dextromethorphan, phenylpropanolamine and caffeine | Takeda Chemical Industries, Ltd. (JP) | 1995-01-04 | — | — | EP | disclosed |
| JP-H05139996-A | COMPOSITION FOR ANTITUSSIVE EXPECTORANT REDUCED IN ITS BITTER TASTE | LION CORP | 1993-06-08 | — | — | JP | disclosed |
| JP-S6272688-A | TIPEPIDINE CITRATE-CONTAINING COMPOSITION | SS PHARMACEUT CO LTD | 1987-04-03 | — | — | JP | disclosed |
| JP-S06272688-A | — | — | 0001-01-01 | — | — | JP | disclosed |